AbbVie is trading 3.05% up at $282.73 on October 14, 2026, amid healthcare-sector strength despite a weaker broader-market backdrop. - The healthcare sector is up 1.64%, supported by UnitedHealth’s earnings beat and higher profit outlook. - No clear company-specific announcement explaining AbbVie’s gain surfaced. Phase 3 Skyrizi data reported October 13 are company news, but available coverage does not establish them as the cause of today’s rise.